A Rare Presentation of Pneumonic-Type Adenocarcinoma Hidden behind Empyema

Satoru Senoo1, Eito Niman2, Ryoko Tsuji1

  • 1Department of Respiratory Medicine, National Hospital Organization Fukuyama Medical Center.

Acta Medica Okayama
|August 27, 2025
PubMed

Insights

Pneumonic-type adenocarcinoma (P-ADC) can mimic pneumonia. Early bronchoscopy is crucial for diagnosing P-ADC when pneumonia-like shadows enlarge after empyema treatment.

Area of Science:

  • Pulmonology
  • Oncology
  • Radiology

Background:

  • Pneumonic-type adenocarcinoma (P-ADC) presents a diagnostic challenge due to its radiographic similarity to pneumonia.
  • Distinguishing P-ADC from infectious pneumonia is critical for appropriate patient management.

Observation:

  • A 50-year-old male initially diagnosed with pneumonia, pulmonary abscess, and empyema showed clinical and laboratory improvement with standard treatment.
  • Despite initial improvement, serial chest computed tomography revealed an enlarging infiltrative shadow, suggesting an unresolved or progressive underlying pathology.

Findings:

  • Bronchoscopy confirmed the presence of adenocarcinoma in the patient with the enlarging infiltrative shadow.
  • The case illustrates a P-ADC initially misdiagnosed as pneumonia that progressed to abscess and empyema.

Implications:

  • This case underscores the necessity of including P-ADC in the differential diagnosis for persistent or enlarging pneumonia-like lung opacities, especially after empyema treatment.
  • Prompt diagnostic procedures, such as bronchoscopy, are vital for accurate diagnosis and timely initiation of oncological treatment in suspected P-ADC cases.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
329
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
355
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
342
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
549
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
435
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
267